Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035469 | SCV000059117 | likely benign | not specified | 2008-03-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001185549 | SCV001351798 | likely benign | Cardiomyopathy | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001487079 | SCV001691563 | likely benign | Hypertrophic cardiomyopathy | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668152 | SCV001888740 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162300 | SCV003911241 | likely benign | Cardiovascular phenotype | 2022-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001487079 | SCV004842387 | likely benign | Hypertrophic cardiomyopathy | 2023-08-28 | criteria provided, single submitter | clinical testing |